[EN] BIPHENYL SULFONAMIDES AS DUAL ANGIOTENSIN ENDOTHELIN RECEPTOR ANTAGONISTS [FR] BIPHÉNYL-SULFONAMIDES EN TANT QUE DOUBLES ANTAGONISTES DES RÉCEPTEURS DE L'ENDOTHÉLINE ET DE L'ANGIOTENSINE
[EN] BIPHENYL SULFONAMIDES AS DUAL ANGIOTENSIN ENDOTHELIN RECEPTOR ANTAGONISTS [FR] BIPHÉNYL-SULFONAMIDES EN TANT QUE DOUBLES ANTAGONISTES DES RÉCEPTEURS DE L'ENDOTHÉLINE ET DE L'ANGIOTENSINE
[EN] BIPHENYL SULFONAMIDES AS DUAL ANGIOTENSIN ENDOTHELIN RECEPTOR ANTAGONISTS<br/>[FR] BIPHÉNYLE SULFONAMIDES EN TANT QUE DOUBLES ANTAGONISTES DU RÉCEPTEUR D'ANGIOTENSINE ET D'ENDOTHÉLINE
申请人:LIGAND PHARM INC
公开号:WO2009158309A2
公开(公告)日:2009-12-30
The present invention provides novel biphenyl sulfonamide compounds which are combined angiotensin and endothelin receptor antagonists useful in the treatment of conditions such as hypertension and other diseases.
[EN] BIPHENYL SULFONAMIDES AS DUAL ANGIOTENSIN ENDOTHELIN RECEPTOR ANTAGONISTS<br/>[FR] BIPHÉNYL-SULFONAMIDES EN TANT QUE DOUBLES ANTAGONISTES DES RÉCEPTEURS DE L'ENDOTHÉLINE ET DE L'ANGIOTENSINE
申请人:LIGAND PHARM INC
公开号:WO2009155448A1
公开(公告)日:2009-12-23
Biphenyl sulfonamide compounds are disclosed that are combined- angiotensin and endothelin receptor antagonists useful in the treatment of conditions such as hypertension and other diseases. Compounds of the general formula I as disclosed herein and pharmaceutically acceptable salts thereof are disclosed, as are uses thereof and pharmaceutical compositions comprising such compounds.